Physiology of breathlessness associated with pleural effusions

Abstract

Purpose of reviewPleural effusions have a major impact on the cardiorespiratory system. This article reviews the pathophysiological effects of pleural effusions and pleural drainage, their relationship with breathlessness, and highlights key knowledge gaps.Recent findingsThe basis for breathlessness in pleural effusions and relief following thoracentesis is not well understood. Many existing studies on the pathophysiology of breathlessness in pleural effusions are limited by small sample sizes, heterogeneous design and a lack of direct measurements of respiratory muscle function. Gas exchange worsens with pleural effusions and improves after thoracentesis. Improvements in ventilatory capacity and lung volumes following pleural drainage are small, and correlate poorly with the volume of fluid drained and the severity of breathlessness. Rather than lung compression, expansion of the chest wall, including displacement of the diaphragm, appears to be the principle mechanism by which the effusion is accommodated. Deflation of the thoracic cage and restoration of diaphragmatic function after thoracentesis may improve diaphragm effectiveness and efficiency, and this may be an important mechanism by which breathlessness improves. Effusions do not usually lead to major hemodynamic changes, but large effusions may cause cardiac tamponade and ventricular diastolic collapse. Patients with effusions can have impaired exercise capacity and poor sleep quality and efficiency.SummaryPleural effusions are associated with abnormalities in gas exchange, respiratory mechanics, respiratory muscle function and hemodynamics, but the association between these abnormalities and breathlessness remains unclear. Prospective studies should aim to identify the key mechanisms of effusion-related breathlessness and predictors of improvement following pleural drainage.

The Silent And Apparent Neurological Injury In Transcatheter Aortic Valve Implantation (Sanity) Study

“…Isolates from two previously described 2013 cases [1] possessed the same sequence types, supporting the hypothesis of a common source of infection.…”

Expanding knowledge on non‐expandable lungs

“…In the Australasian Malignant PLeural Effusion trial‐2, patients with NEL could develop autopleurodesis especially if drained daily via an indwelling pleural catheter (IPC). Clinicians must also discard the old belief that patients with NEL will not derive symptom benefits from fluid drainage (reviewed elsewhere) …”

“…Clinicians must also discard the old belief that patients with NEL will not derive symptom benefits from fluid drainage (reviewed elsewhere). 8 How should clinicians approach NEL knowing it may require years, if not decades, for research studies to provide a full picture of how best to define, assess and employ NEL for selecting patients for pleurodesis? Research in MPE care has been progressing rapidly in the past decade and the latest finding raises the possibility of bypassing the need of defining NEL.…”

Management of Malignant Pleural Effusions—What Is New

“…However, the pathophysiology behind MPE-related breathlessness is poorly understood. 96 Not surprisingly, recent studies found that a sizeable number (15-27%) of patients had no symptomatic improvement after therapeutic drainage. Understanding the mechanism of MPE-related breathlessness is critical to aid patient selection for pleural interventions.…”